瑞典的研究显示,精密医学利用基因特征分析改进了对抗转移性剖析前列腺癌的治疗。 Swedish study shows precision medicine improves treatment of metastatic castration-resistant prostate cancer using genetic profiling.
瑞典的一项研究显示,精准医学通过使用基因分析来确定第二代激素药物的有效性, 改善了对转移性,抗割的前列腺癌的治疗. A Swedish study shows precision medicine improves treatment of metastatic castration-resistant prostate cancer by using genetic profiling to determine the effectiveness of second-generation hormone drugs. ProBio研究发表在《自然医学》上,该研究显示,有特定肿瘤突变的病人对甲状腺素受体途径抑制剂(ARPi)的反应更好,这些抑制剂的预期寿命比化疗长。 The ProBio study, published in Nature Medicine, reveals patients with specific tumor mutations respond better to Androgen Receptor Pathway inhibitors (ARPi), which have longer life expectancy than chemotherapy. 这项研究表明,精密医学可以改善对患有转移性前列腺癌的男子的治疗。 This research suggests that precision medicine can improve treatment for men with metastatic prostate cancer.